Hydrocortisone aceponate Ecuphar (previously Cortacare)

RSS

hydrocortisone aceponate

Authorised
This medicine is authorised for use in the European Union.

Overview

Hydrocortisone aceponate Ecuphar is a corticosteroid veterinary medicine used to treat inflamed and itchy skin conditions in dogs. It is also used to treat symptoms of itchy skin in dogs prone to allergies (atopic dermatitis).

Hydrocortisone aceponate Ecuphar contains the active substance hydrocortisone aceponate and is a ‘hybrid medicine’. This means that it is similar to a ‘reference medicine’ containing the same active substance. The reference medicine for Hydrocortisone aceponate Ecuphar is Cortavance.

This EPAR was last updated on 04/01/2022

Authorisation details

Product details
Name
Hydrocortisone aceponate Ecuphar (previously Cortacare)
Agency product number
EMEA/V/C/004689
Active substance
hydrocortisone aceponate
International non-proprietary name (INN) or common name
hydrocortisone aceponate
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QD07AC
Publication details
Marketing-authorisation holder
Ecuphar
Revision
3
Date of issue of marketing authorisation valid throughout the European Union
27/08/2018
Contact address
Legeweg 157-i B-8020
Oostkamp 8020
Oostkamp
Belgium

Product information

17/12/2021 Hydrocortisone aceponate Ecuphar (previously Cortacare) - EMEA/V/C/004689 - IB/0005/G

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Corticosteroids, dermatological preparations

Therapeutic indication

For symptomatic treatment of inflammatory and pruritic dermatoses in dogs.

For alleviation of clinical signs associated with atopic dermatitis in dogs.

Assessment history

How useful was this page?

Add your rating
Average
2 ratings